Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

FDA's AdComm Says Avenue Therapeutics Submitted Insufficient Data On IV Tramadol

Avenue Therapeutics Inc (NASDAQ: ATXI) announced the outcome of the FDA meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee on IV tramadol.

Benzinga

Patients’ groups, progressives square off over Medicare Alzheimer’s decision

WASHINGTON — Advocates on both sides of a debate over dramatically restricting Medicare’s coverage of an expensive and controversial Alzheimer’s treatment are waging competing campaigns to influence a final decision in April.

Tribune News Service

Senate confirms Robert Califf to become Biden’s FDA commissioner

WASHINGTON — The Senate on Tuesday confirmed Robert Califf to lead the Food and Drug Administration, 50-46, a much narrower vote than when he previously held the position during the Obama administration, though many thought the latest vote could be even closer.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Senate confirms Robert Califf as FDA commissioner

The agency has been without a permanent leader for more than a year.

Axios

Senate confirms Biden's FDA pick despite political divisions

The Senate has narrowly confirmed President Joe Biden’s pick to lead the Food and Drug Administration, filling a position that had been open for more than a year

The Independent UK

Is Senseonics Holdings a Smart Investment in 2022?

The shares of medical technology stock Senseonics Holdings (SENS) dipped marginally in price yesterday, despite the company receiving FDA approval for its Eversense E3 glucose monitoring system. So, with unsustainable valuations and a bleak earnings outlook, will SENS'stock be able to regain forward momentum soon? Read more to learn our…

StockNews.com

FDA Signs Off Citius Pharma's Phase 2 Trial With Halo-Lido In Hemorrhoids

The

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Patients' groups, progressives square off over Medicare Alzheimer's decision - Roll Call

Competing campaigns look to influence the debate over dramatically restricting coverage of a controversial treatment drug Aduhelm.

Roll Call

Senate confirms Califf to become Biden's FDA commissioner - Roll Call

Six Republicans voted Tuesday to confirm FDA nominee Robert Califf, who had seen opposition from pockets of the Democratic caucus.

Roll Call

FDA Slams Brakes On Legend Biotech's CAR-T Therapy Trial In Lymphoma Patients

The FDA has instituted a clinical hold on Legend Biotech Corporation's (NASDAQ:

Benzinga

Jury finds New York Times did not defame Sarah Palin – as it happened

Former Republican vice-presidential nominee sued the newspaper in 2017 claiming an editorial damaged her career

The Guardian - US

The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

After the FDA issued warnings about antidepressants, youth suicides rose and mental health care dropped

Depression in young people is vastly undertreated. About two-thirds of depressed youth don’t receive any mental health care at all. Of those who do, a significant proportion rely on antidepressant medications.

The Conversation

Larimar Stock Plunges As FDA Asks For Additional Data To Resolve Clinical Hold On Friedreich's Ataxia Program

Larimar Therapeutics Inc (NASDAQ: LRMR) has rec

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Bangkok Post

Medical goods among B30m of fake products seized at warehouse

Consumer protection police and Food and Drug Administration (FDA) officials seized a large quantity of falsely labelled, sub-standard products worth about 30 million baht at a warehouse in Khlong Luang district, Pathum Thani province.

Tribune News Service

Commentary: What we can learn about cancer drug development from the COVID-19 approach

As an oncologist, I recognize the arduous path to make a new drug. It is a hard trek that lies between the bench and the patient’s bedside. Ordinarily, it takes five or more years just to get a new drug into the clinic for testing. Similar time is needed for…

Benzinga

Weed'n Whiskey: Why Tilray Thinks There Is Gold In Cannabis-Infused Whiskey

This article was originally published on Cannabis.net and appears here with permission.

Roll Call

Senate sets up Califf confirmation vote with narrow procedural win - Roll Call

The nominee to lead the FDA, Robert Califf, survived a Senate procedural vote Monday with the help of five Republicans.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Pfizer Shares Are Trading Lower Today

Pfizer Inc (NYSE: PFE) is trading lower Monday after the U.S. Food and Drug Administration (FDA) requested additional data before approving its COVID-19 vaccine for children aged six months to four years old.

Benzinga

Why BioNTech Shares Are Falling Today

BioNTech SE (NASDAQ: BNTX) is trading lower Monday morning after the U.S. Food and Drug Administration (FDA) requested additional data before approving its COVID-19 vaccine for children aged six months to four years old.

Benzinga

FDA Clears Cidara Therapeutics' Phase 1 Trial For Immunotherapeutic Antiviral For Influenza

The

Benzinga

Denali Receives Formal Letter Regarding FDA Hold On Alzheimer's Potential Program

As previously announced, Denali Therapeutics Inc (NASDAQ: DNLI) was informed via e-mail communication from the FDA that DNL919 (ATV:TREM2) Investigational New Drug (IND) application was placed on clinical hold.

McClatchy Washington Bureau

New monoclonal antibody drug for COVID-19 authorized, FDA says. It works against omicron

A new monoclonal antibody drug has proved to be effective against the coronavirus omicron variant and omicron subvariant, according to the Food and Drug Administration.

Axios

Experts praise Pfizer's delay on kids' vaccines

Experts say waiting for data on three doses is the right call.

Salon

Covid vaccine for young kids delayed

The FDA says it needs more time to review data on a potential three-dose vaccine for children aged 6 months to four

1 … 257 258 259 260

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.